BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7249377)

  • 1. Specific interaction between placental protein 5 and thrombin.
    Jones GR; Davey MW; Teisner B; Grudzinskas JG
    Clin Chim Acta; 1981 Jul; 114(1):75-82. PubMed ID: 7249377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental protein 5 is related to blood coagulation and fibrinolytic systems.
    Siiteri JE; Koistinen R; Salem HT; Bohn H; Seppälä M
    Life Sci; 1982 May; 30(22):1885-91. PubMed ID: 6213827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of thrombin on serum placental protein 5 (PP5): is PP5 the naturally occurring antithrombin III of the human placenta?
    Salem HT; Seppälä M; Chard T
    Placenta; 1981; 2(3):205-9. PubMed ID: 7279875
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of pergonal on in vitro production of placental protein 5 (PP5) by ovarian tumour cells.
    Sinosich MJ; Dodd J; Hudson CN; Tyler JR; Seppala M; Grudzinskas JG; Saunders DM
    Tumour Biol; 1985; 6(3):233-42. PubMed ID: 2416032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental protein 5 (PP5) inhibits thrombin-induced coagulation of fibrinogen.
    Meisser A; Bischof P; Bohn H
    Arch Gynecol; 1985; 236(4):197-201. PubMed ID: 4026390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental protein 5 (PP5) in pregnancy and malignant disease: the influence of heparin binding.
    Nisbet AD; Brenner RD; Horne CH; Bohn H
    Clin Chim Acta; 1982 Feb; 119(1-2):21-9. PubMed ID: 7060273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interaction between placental protein 5 and heparin.
    Jones GR; Davey MW; Sinosich M; Grudzinskas JG
    Clin Chim Acta; 1981 Feb; 110(1):65-70. PubMed ID: 7214716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of placental protein 5 (PP5) in late pregnancy serum and plasma: evidence for a heparin-PP5 polymer.
    Salem HT; Obiekwe BC; Al-Ani AT; Seppälä M; Chard T
    Clin Chim Acta; 1980 Nov; 107(3):211-5. PubMed ID: 7438456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic and biological properties and clinical significance of placental proteins PP5 and PP12.
    Seppälä M; Rutanen EM; Siiteri JE; Wahlström T; Koistinen R; Pietilä R; Bohn H
    Ann N Y Acad Sci; 1983; 417():368-82. PubMed ID: 6322659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of placental protein 5.
    Bützow R; Huhtala ML; Bohn H; Virtanen I; Seppälä M
    Biochem Biophys Res Commun; 1988 Jan; 150(1):483-90. PubMed ID: 3276312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of protamine on serum levels of placental protein 5 (PP5) in normal and abnormal pregnancy: a possible relation to coagulation abnormalities.
    Salem HT; Seppälä M; Ranta T; Bohn H; Chard T
    Br J Obstet Gynaecol; 1981 Apr; 88(4):367-70. PubMed ID: 7225294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental protein 5 in benign and malignant ovarian cyst fluids.
    Than G; Seppälä M; Csaba I; Iino K; Briese V
    Tumour Biol; 1987; 8(4):230-1. PubMed ID: 3448769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts.
    Udagawa K; Yasumitsu H; Esaki M; Sawada H; Nagashima Y; Aoki I; Jin M; Miyagi E; Nakazawa T; Hirahara F; Miyazaki K; Miyagi Y
    Placenta; 2002; 23(2-3):145-53. PubMed ID: 11945080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental protein 5 in fetal and maternal compartments.
    Grudzinskas JG; Charnock M; Obiekwe BC; Gordon YB; Chard T
    Br J Obstet Gynaecol; 1979 Aug; 86(8):642-4. PubMed ID: 497134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties.
    Koistinen R; Huhtala ML; Stenman UH; Seppälä M
    Clin Chim Acta; 1987 May; 164(3):293-303. PubMed ID: 3109787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for the purification of placental protein 5 (PP5) from placental extracts.
    Rice A; Chard T
    Clin Chim Acta; 1983 Jul; 131(3):289-94. PubMed ID: 6883723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorometric demonstration and quantification of placental protein 5 in the absence of pregnancy.
    Bützow R; Alfthan H; Stenman UH; Suikkari AM; Bohn H; Seppälä M
    Clin Chem; 1988 Aug; 34(8):1591-3. PubMed ID: 3402060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-associated plasma protein-A and placental protein 5 in human ovarian follicular fluid.
    Sinosich MJ; Saunders DM; Grudzinskas JG
    Ann N Y Acad Sci; 1985; 442():269-75. PubMed ID: 2409857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental protein 5 (PP5) in placental abruption.
    Salem HT; Westergaard JG; Hindersson P; Seppälä M; Chard T
    Br J Obstet Gynaecol; 1981 May; 88(5):500-3. PubMed ID: 7236553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
    Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.